SI
SHOULDER INNOVATIONS, INC.
NYSE · Healthcare · Medical - Specialties · US
$20.20
−1.20%Year over year
Reported trailing growth
- Revenue
- +60.9%
- EBITDA
- -9.9%
- EBIT
- —
- EPS
- -8.9%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +34.0%
- EBITDA
- +4.5%
- EPS
- -1.5%
Three-year CAGR
- Revenue
- +56.7%
- EBITDA
- —
- EBIT
- -79.5%
- Net income
- —
- EPS
- —
- Free cash flow
- -98.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026